Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
T2DM risk reduced by 39 percent for those with high adherence to antimalarial therapy for managing lupus.
Diabetes Mellitus
Frailty Ups Urinary Stone Risk in Diabetics
New findings suggest that it may be possible to direct interventions toward frailty to ameliorate urolithiasis risk in patients with diabetes.
Metformin Use Associated With Lower Death Risk in Type 2 Diabetes
In a study of patients with type 2 diabetes at high cardiovascular (CV) risk, metformin use decrease the risk of all-cause mortality but had no significant effect on a composite end point of CV death, MI, or ischemic stroke.
Dapagliflozin Shown to Slow Diabetic Kidney Disease Progression
Protective effect is driven largely by a sustained 40% decrease in estimate glomerular filtration rate to below 60 mL/min/1.73 m2.
FDA Grants Priority Review for Canagliflozin to Treat CKD in T2DM
If approved, canagliflozin would be the first drug in almost 20 years indicated to treat CKD in patients with type 2 diabetes when added to current standard of care, according to the drug’s maker.
GFR Decline Tied to Protein Intake in Diabetic Blacks
The percentage decline in estimated glomerular filtration rate over an 8-year period was greater among those with vs without diabetes across all quintiles of protein intake.
Delayed-release Niacin Benefits Prediabetes, Diabetes
Delayed-release Niacin may be beneficial to patients with prediabetes and type 2 diabetes.
Pre-Op Liraglutide Reduces Post-Op Plasma Glucose in Diabetes Pts
In patients with T2DM, taking liraglutide before surgery may be associated with reduced post-op plasma glucose levels.
FDA Approves Short Acting Insulin Drug for Diabetes
The FDA just approved a new short-acting insulin drug, Admelog, for patients with either T1D or T2D.
Primary Care-led Weight Loss Leads to T2DM Remission
Remission was linked to 46% patients in intensive weight management programs.
-
Loading...
-
Loading...
